NEW YORK (GenomeWeb News) – GeneLink said yesterday that the Superior Court of Pennsylvania has affirmed the dismissal of a complaint filed against the company by its former President and CEO, John DePhillipo, and his wife.
DePhillipo had appealed a dismissal ruling handed down by the Court of Common Pleas of Pennsylvania, Philadelphia County, in May 2009.
As GenomeWeb Daily News reported at the time, the court dismissed the suit, for damages the plaintiff valued at around $20 million, on the grounds that the claims "were not viable," according to the company.
DePhillipo filed the suit with the claim that the company had misrepresented its financial status in a previous settlement between the two parties.
GeneLink is developing genetic tests and personalized wellness products, such as nutritional supplements and skin care products based on its DNA research.